Theron Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: Sunnyvale CA United States (2008)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2014
NCT02133339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

tiotropium (spiriva) (1 trial)

trn-157 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Lung Diseases, Obstructive (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2